Enanta Pharmaceuticals | 8-K: Current report
Mar 12 16:04 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Vance Terry
Mar 8 17:32 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Russell Lesley
Mar 8 17:31 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Peterson Kristine
Mar 8 17:27 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hata Yujiro S
Mar 8 17:23 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FOLETTA MARK G
Mar 8 17:17 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CARTER BRUCE L A
Mar 8 17:16 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gardiner Nathaniel S.
Feb 27 18:37 ET
Enanta Pharmaceuticals | SCHEDULE 13G: Others
Feb 27 13:16 ET
Enanta Pharmaceuticals | UPLOAD: Others
Feb 26 14:26 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Luu Brendan
Feb 14 20:28 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kieffer Tara Lynn
Feb 14 20:23 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gardiner Nathaniel S.
Feb 14 20:23 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rottinghaus Scott T.
Feb 14 20:18 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Or Yat Sun
Feb 14 20:18 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MELLETT PAUL J
Feb 14 20:13 ET
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Luly Jay R.
Feb 14 20:03 ET
Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.80%),Steven Boyd(9.80%)
Feb 14 15:30 ET
Enanta Pharmaceuticals | CORRESP: CORRESP
Feb 14 14:26 ET
Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.52%)
Feb 13 18:00 ET
No Data
No Data